NEW YORK ( TheStreet) -- CHANGE IN RATINGS Alcoa ( AA) downgraded at Jefferies to Hold from Buy, Jefferies said. LME aluminum inventories are near record highs. Abbott Laboratories ( ABT) downgraded at Leerink to Market Perform, Leerink Swann said. Stock is up 30% since last October and appears fairly valued ahead of the upcoming business split. Access Midstream Partners ( ACMP) upgraded at Citigroup to Buy from Neutral, Citigroup said. $35 price target. Improved drop down visibility and counterparty risk profile. A.H. Belo Corporation ( AHC) upgraded to hold at TheStreet Ratings. Albemarle Corporation ( ALB) rated new Equal-weight at Morgan Stanley. More upside potential in other chemical "Big Ideas." Arrow Electronics ( ARW) downgraded at Miller Tabak from Buy to Neutral, Miller Tabak said. $41 price target. Estimates also cut, given lower expected near-term demand. BCSB Bankcorp ( BCSB) downgraded to hold at TheStreet Ratings. Bloomin Brands ( BLMN) rated new Neutral at Deutsche. $16 price target. Company will struggle to receive a higher multiple. BMC Software ( BMC) upgraded at Think Equity to Buy from Hold, Think said. $50 price target. ESM business has bottomed. Broadcom ( BRCM) upgraded at RBC from Sector Perform to Outperform, RBC Capital said. $46 price target. Company has a solid product pipeline. Boston Scientific ( BSX) downgraded at Leerink to Market Perform, Leerink Swann said. $6 price target. Company will struggle to grow in declining markets. Dover Corp ( DOV) rated new Neutral at Citigroup. $64 price target. Still in transition with plenty of energy. Fairchild Semiconductor ( FCS) downgraded at Miller Tabak from Buy to Neutral, Miller Tabak said. $16 price target. Company is leveraged to slower macro growth. Intel ( INTC) downgraded at RBC from Outperform to Sector Perform, RBC Capital said. $24 price target. PC market faces near-term headwinds. Lamar Advertising ( LAMR) upgraded at Goldman from Neutral to Buy, Goldman Sachs said. Company also placed on the Conviction List. $42 price target. Expect value from a likely REIT conversion. Manhattan Associates ( MANH) upgraded at Think to Buy from Hold, ThinkEquity said. $67 price target. Steady IT spending trends. Molina Healthcare ( MOH) downgraded at Jefferies to Underperform from Hold, Jefferies said. $19 price target. Poor execution. Marathon Petroleum ( MPC) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. Valuation call, based on a $65 price target.
Nvidia ( NVDA) downgraded at RBC from Outperform to Sector Perform, RBC Capital said. $15 price target. Slower PC growth could weigh on the next few quarters. Pall Corporation ( PLL) upgraded at BofA Merrill to Neutral from Underperform, Bank of America Merrill Lynch said. $65 price target. Shares appear fairly valued. Panera Bread ( PNRA) downgraded at Miller Tabak to Hold from Buy, Miller Tabak said. $172 price target. Valuation call. Perrigo ( PRGO) rated new Buy at Guggenheim. $130 price target. FDA could approve for drug classes for over-the-counter status. Phillips 66 ( PSX) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $53 price target. Higher industry capacity could hurt margins. Schnitzer Steel ( SCHN) downgraded at Jefferies. Shares of SCHN now seen reaching $31, Jefferies said. $31 price target. Steel prices poised for a material pull back. Silicon Laboratories ( SLAB) downgraded at Miller Tabak from Buy to Neutral, Miller Tabak said. Valuation call, based on a $41 price target. Texas Instruments ( TXN) downgraded at RBC from Outperform to Sector Perform, RBC Capital said. $28 price target. Company is seeing lower end-market demand. Watson Pharmaceuticals ( WPI) rated new Buy at Guggenheim. $100 price target. Large generics should benefit from new legislation.
Twitter and become a fan on Facebook.
STOCK COMMENTS / EPS CHANGESApple ( AAPL) estimates, target raised at Sterne Agee. Shares of AAPL now seen reaching $840, according to Sterne Agee. Estimates also increased, given higher realized iPhone sales. Buy rating. Apple estimates, target increased at BofA/Merrill. AAPL estimates were raised through 2014, Bank of America/Merrill Lynch said. Expect higher demand for the iPhone 5. Buy rating and new $850 price target. Amazon.com ( AMZN) estimates upped at Topeka through 2013, Topeka Capital Markets said. Kindle Fire HD can drive near-term growth. Buy rating and $400 price target. Actuant ( ATU) numbers raised at UBS. Shares of ATU now seen reaching $34, UBS said. Estimates also increased post management visit. Buy rating. Boeing ( BA) estimates, target reduced at Credit Suisse. Shares of BA now seen reaching $87.50, according to Credit Suisse. Estimates also cut, given pension headwinds. Outperform rating. Bed Bath & Beyond ( BBBY) numbers raised at UBS. Shares of BBBY now seen reaching $72.60, UBS said. Estimates also increased as shares reflect more optimism since Q1 results. Neutral rating. Eaton ( ETN) target raised at Oppenheimer to $58, Oppenheimer said. Multiple accretion looks solid. Outperform rating. Health Net ( HNT) numbers raised at BMO Capital. Shares of HNT now seen reaching $17, BMO said. Estimates also raised on surge of dual enrollment. Underperform rating. Huntsman ( HUN) numbers raised at Jefferies. Shares of HUN now seen reaching $16, Jefferies said. Estimates also raised on cost- cutting tailwinds. Hold rating. Questcor Pharmaceuticals ( QCOR) numbers raised at Oppenheimer. Shares of QCOR now seen reaching $69, Oppenheimer said. Estimates also raised following positive commentary. Outperform rating. >To submit a news tip, email: firstname.lastname@example.org.
READERS ALSO LIKE:
Twitter and become a fan on Facebook.